Armata 
Welcome,         Profile    Billing    Logout  
 8 Products   25 Diseases  8 Products   6 Trials   83 News 
9 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Mydicar (AAV1/SERCA2a) / Armata, Theragene
MUSIC-HFrEF1, NCT04703842: Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction

Recruiting
1/2
57
US
SRD-001, Placebo
Sardocor Corp., Covance
Congestive Heart Failure, Heart Failure, Systolic, Heart Failure, HFrEF - Heart Failure With Reduced Ejection Fraction
12/25
12/28
MUSIC-HFpEF, NCT06061549: Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Preserved Ejection Fraction

Recruiting
1b
10
US
AAV1/SERCA2a
Sardocor Corp.
Heart Failure, Diastolic, Heart Failure With Preserved Ejection Fraction
08/25
08/29
MUSIC-DMD, NCT06224660: Modulation of SERCA2a of Intra-Myocytic Calcium Trafficking in Cardiomyopathy Secondary to Duchenne Muscular Dystrophy

Recruiting
1
12
US
SRD-001, AAV1/SSERCA2a
Sardocor Corp.
DMD-Associated Dilated Cardiomyopathy
10/27
10/30
tgAAG76 / Armata, University College London
2006-001571-37: AN OPEN-LABEL DOSE ESCALATION STUDY OF AN ADENO-ASSOCIATED VIRUS VECTOR (AAV2/2-hRPE65p-hRPE65) FOR GENE THERAPY OF SEVERE EARLY-ONSET RETINAL DEGENERATION

Ongoing
2
12
Europe
tgAAG76,
University College London
The condition to be investigated is severe early-onset inherited retinal degeneration due to defects in the gene encoding RPE65
 
 
AmpliPhage-001 / Armata
NCT03395743: Individual Patient Expanded Access for AB-PA01, an Investigational Anti-Pseudomonas Aeruginosa Bacteriophage Therapeutic

No Longer Available
N/A
NA
AB-PA01
Armata Pharmaceuticals, Inc.
 
 
AP-SA01 / Armata
NCT03395769: Individual Patient Expanded Access for AB-SA01, an Investigational Anti-Staphylococcus Aureus Bacteriophage Therapeutic

No Longer Available
N/A
NA
AB-SA01
Armata Pharmaceuticals, Inc.
 
 
AP-PA02 / Armata
Tailwind, NCT05616221: Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection

Completed
2
48
US
AP-PA02, Placebo
Armata Pharmaceuticals, Inc.
Non-cystic Fibrosis Bronchiectasis, Pseudomonas Aeruginosa, Lung Infection
07/24
08/24
SWARM-Pa, NCT04596319: Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis

Completed
1/2
29
US
AP-PA02, Placebo
Armata Pharmaceuticals, Inc., Cystic Fibrosis Foundation
Cystic Fibrosis, Pseudomonas Aeruginosa, Pseudomonas, Lung Infection, Lung Infection Pseudomonal
12/22
12/22
AP-SA02 / Armata
diSArm, NCT05184764: Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects with S. Aureus Bacteremia

Completed
1/2
50
US, RoW
AP-SA02, Placebo
Armata Pharmaceuticals, Inc., United States Department of Defense
Bacteremia, Staphylococcus Aureus, Staphylococcus Aureus Bacteremia, Bacteremia Staph, Bacteremia Due to Staphylococcus Aureus
01/24
01/25
AP-PA03 / Armata
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Mydicar (AAV1/SERCA2a) / Armata, Theragene
MUSIC-HFrEF1, NCT04703842: Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction

Recruiting
1/2
57
US
SRD-001, Placebo
Sardocor Corp., Covance
Congestive Heart Failure, Heart Failure, Systolic, Heart Failure, HFrEF - Heart Failure With Reduced Ejection Fraction
12/25
12/28
MUSIC-HFpEF, NCT06061549: Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Preserved Ejection Fraction

Recruiting
1b
10
US
AAV1/SERCA2a
Sardocor Corp.
Heart Failure, Diastolic, Heart Failure With Preserved Ejection Fraction
08/25
08/29
MUSIC-DMD, NCT06224660: Modulation of SERCA2a of Intra-Myocytic Calcium Trafficking in Cardiomyopathy Secondary to Duchenne Muscular Dystrophy

Recruiting
1
12
US
SRD-001, AAV1/SSERCA2a
Sardocor Corp.
DMD-Associated Dilated Cardiomyopathy
10/27
10/30
tgAAG76 / Armata, University College London
2006-001571-37: AN OPEN-LABEL DOSE ESCALATION STUDY OF AN ADENO-ASSOCIATED VIRUS VECTOR (AAV2/2-hRPE65p-hRPE65) FOR GENE THERAPY OF SEVERE EARLY-ONSET RETINAL DEGENERATION

Ongoing
2
12
Europe
tgAAG76,
University College London
The condition to be investigated is severe early-onset inherited retinal degeneration due to defects in the gene encoding RPE65
 
 
AmpliPhage-001 / Armata
NCT03395743: Individual Patient Expanded Access for AB-PA01, an Investigational Anti-Pseudomonas Aeruginosa Bacteriophage Therapeutic

No Longer Available
N/A
NA
AB-PA01
Armata Pharmaceuticals, Inc.
 
 
AP-SA01 / Armata
NCT03395769: Individual Patient Expanded Access for AB-SA01, an Investigational Anti-Staphylococcus Aureus Bacteriophage Therapeutic

No Longer Available
N/A
NA
AB-SA01
Armata Pharmaceuticals, Inc.
 
 
AP-PA02 / Armata
Tailwind, NCT05616221: Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection

Completed
2
48
US
AP-PA02, Placebo
Armata Pharmaceuticals, Inc.
Non-cystic Fibrosis Bronchiectasis, Pseudomonas Aeruginosa, Lung Infection
07/24
08/24
SWARM-Pa, NCT04596319: Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis

Completed
1/2
29
US
AP-PA02, Placebo
Armata Pharmaceuticals, Inc., Cystic Fibrosis Foundation
Cystic Fibrosis, Pseudomonas Aeruginosa, Pseudomonas, Lung Infection, Lung Infection Pseudomonal
12/22
12/22
AP-SA02 / Armata
diSArm, NCT05184764: Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects with S. Aureus Bacteremia

Completed
1/2
50
US, RoW
AP-SA02, Placebo
Armata Pharmaceuticals, Inc., United States Department of Defense
Bacteremia, Staphylococcus Aureus, Staphylococcus Aureus Bacteremia, Bacteremia Staph, Bacteremia Due to Staphylococcus Aureus
01/24
01/25
AP-PA03 / Armata
No trials found

Download Options